Evolution of extracorporeal membrane oxygenation (ECMO) in neonatal acute respiratory failure, fifteen years of experience;Évolution sur 15 ans de l'assistance respiratoire extra-corporelle dans la prise en charge des détresses respiratoires néonatales sévères

Archives de Pediatrie

Volumn 11, Issue 4, 2004, Pages 308-314

  Flamant, C ^a   Nolent, P ^a   Hallalel, F ^a   Lardeux, C ^a   Chevalier, J Y ^a   Renolleau, S ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Assistance respiratoire extra corporelle; Extracorporeal membrane oxygenation; Infant, newborn; Nouveau n

Indexed keywords

ACUTE RESPIRATORY FAILURE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EVALUATION; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; INFANT; INTENSIVE CARE UNIT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MECONIUM ASPIRATION; NEWBORN; RETROSPECTIVE STUDY; SURVIVAL RATE; HOSPITALIZATION; HYPOXEMIA; METHODOLOGY; NEONATAL RESPIRATORY DISTRESS SYNDROME; TREATMENT OUTCOME;

ANOXEMIA; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MECONIUM ASPIRATION SYNDROME; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 1842423111     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2004.01.007     Document Type: Article

References (21)

1. UK Collaborative ECMO Trail Group. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet. 348:1996;75-82.
2. Lotze A., Mitchell B.R., Bulas D.I., Zola E.M., Shalwitz R.A., Gunkel J.H., Survanta in Term Infants Study Group. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. J Pediatr. 132:1998;40-47.
3. Finer N.N., Barrington K.J. Nitric oxide in respiratory failure in the newborn infant. Semin Perinatol. 21:1997;426-440.
4. Clark R.H. High-frequency ventilation. J Pediatr. 124:1994;661-670.
5. Bartlett R.H., Roloff D.W., Cornell R.G., Andrews A.F., Dillon P.W., Zwischenberger J.B. Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics. 76:1985;479-487.
6. Chevalier J.Y., Durandy Y., Batisse A., Mathe J.C., Costil J. Preliminary report: extracorporeal lung support for neonatal acute respiratory failure. Lancet. 335:1990;1364-1366.
7. Somme S., Liu D.C. New trends in extracorporeal membrane oxygenation in newborn pulmonary diseases. Artif Organs. 25:2001;633-637.
8. Hintz S.R., Suttner D.M., Sheehan A.M., Rhine W.D., Van Meurs K.P. Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): how new treatment modalities have affected ECMO utilization. Pediatrics. 106:2000;1339-1343.
9. Hoffman G.M., Ross G.A., Day S.E., Rice T.B., Nelin L.D. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. PG. Crit Care Med. 25:1997;352-359.
10. Christou H., Van Marter L.J., Wessel D.L., Allred E.N., Kane J.W., Thompson J.E., et al. Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn. Crit Care Med. 28:2000;3722-3727.
11. Mercier J.C., Lacaze T., Storme L., Roze J.C., Dinh-Xuan A.T., Dehan M., French Paediatric Study Group of Inhaled NO. Disease-related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure. Eur J Pediatr. 157:1998;747-752.
12. Jaillard S., Pierrat V., Truffert P., Metois D., Riou Y., Wurtz A., et al. Two years' follow-up of newborn infants after extracorporeal membrane oxygenation (ECMO). Eur J Cardiothorac Surg. 18:2000;328-333.
13. The Congenital Diaphragmatic Hernia Study Group. Does extracorporeal membrane oxygenation improve survival in neonates with congenital diaphragmatic hernia? J Pediatr Surg. 34:1999;720-724. discussion 724-5.
14. Sreenan C., Etches P., Osiovich H. The western Canadian experience with congenital diaphragmatic hernia: perinatal factors predictive of extracorporeal membrane oxygenation and death. Pediatr Surg Int. 17:2001;196-200.
15. Kossel H., Bauer K., Kewitz G., Karaca S., Versmold H. Do we need new indications for ECMO in neonates pretreated with high-frequency ventilation and/or inhaled nitric oxide? Intensive Care Med. 26:2000;1489-1495.
16. Vaucher Y.E., Dudell G.G., Bejar R., Gist K. Predictors of early childhood outcome in candidates for extracorporeal membrane oxygenation. J Pediatr. 128:1996;109-117.
17. Northway W.H. Jr, Rosan R.C., Porter D.Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 276:1967;357-368.
18. Kornhauser M.S., Baumgart S., Desai S.A., Stanley C.W., Culhane J., Cullen J.A., et al. Adverse neurodevelopmental outcome after extracorporeal membrane oxygenation among neonates with bronchopulmonary dysplasia. J Pediatr. 132:1998;307-311.
19. Beardsmore C., Dundas I., Poole K., Enock K., Stocks J. Respiratory function in survivors of the United Kingdom Extracorporeal Membrane Oxygenation Trial. Am J Respir Crit Care Med. 161:2000;1129-1135.
20. Bennett C.C., Johnson A., Field D.J., Elbourne D., Collaborative Ecmo U.K. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years. Lancet. 357:2001;1094-1096.
21. Rais-Bahrami K., Wagner A.E., Coffman C., Glass P., Short B.L. Neurodevelopmental outcome in ECMO vs near-miss ECMO patients at 5 years of age. Clin Pediatr (Phila). 39:2000;145-152.